$MTVA 3 SEC Filings

Filed On	Filing
13 Oct 2026	Form 3: Browne Sarah Kaplan, Chief Medical Officer No securities owned
02 Nov 2023	Form 3: Tursi James Patrick, Director No securities owned
30 Oct 2023	Form 3: Woodworth Marshall H, Acting Chief Financial Officer No securities owned
12 May 2023	Form 3: Glickman Mark A, Director No securities owned
18 Jan 2023	Form 3: Hooker Joseph, Interim CEO and President No securities owned
22 Nov 2022	Form 3: Goldman Sachs Group Inc, 10% owner and 1 other Holds 1,220,502 shares of Common Stock
02 Feb 2022	Form 3: Strickland D Gordon, Director No securities owned
04 Nov 2021	Form 3: Price Ben Gil, CEO and President No securities owned
19 Jul 2021	Form 3: Kim Hyung Heon, Director No securities owned
19 Jul 2021	Form 3: Koven Andrew I, Director No securities owned
05 Jan 2021	Form 3: Bakshi Akash, Director No securities owned
03 Sep 2020	Form 3: Swirsky Douglas J, Director No securities owned
09 Jan 2020	Form 3: Jk BioPharma Solutions, Inc, 10% owner Holds 1,817,842 shares of Common Stock
09 Jan 2020	Form 3: E&Investment, Inc., 10% owner Holds 4,335,800 shares of Common Stock
09 Jan 2020	Form 3: Dong-a St CO., Ltd, 10% owner Holds 2,880,612 shares of Common Stock
02 Jan 2020	Form 3: Oh Jeong Gyun, Director No securities owned
02 Jan 2020	Form 3: Kim Na Yeon, Director No securities owned
02 Jan 2020	Form 3: Kang Jeong Gu, Director No securities owned
30 Dec 2019	Form 3: Groves Jason L, Director No securities owned
30 Dec 2019	Form 3: Jeong Tae Heum, Director No securities owned

Comments